{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:46:58Z","timestamp":1787500018584,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:00:00Z","timestamp":1590364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:00:00Z","timestamp":1590364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11102-020-01050-2","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T12:02:27Z","timestamp":1590408147000},"page":"498-506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Preconception use of pegvisomant alone or as combination therapy for acromegaly: a case series and review of the literature"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9104-9499","authenticated-orcid":false,"given":"F. J.","family":"Guarda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ghajar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0245-5346","authenticated-orcid":false,"given":"M.","family":"Guitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5708-5231","authenticated-orcid":false,"given":"L. B.","family":"Nachtigall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,25]]},"reference":[{"issue":"1","key":"1050_CR1","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/eje-16-1059","volume":"177","author":"J Abucham","year":"2017","unstructured":"Abucham J, Bronstein MD, Dias ML (2017) Management of endocrine disease: acromegaly and pregnancy: a contemporary review. Eur J Endocrinol 177(1):R1\u2013r12. https:\/\/doi.org\/10.1530\/eje-16-1059","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1050_CR2","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1210\/jcem.84.8.5858","volume":"84","author":"GA Kaltsas","year":"1999","unstructured":"Kaltsas GA, Mukherjee JJ, Jenkins PJ, Satta MA, Islam N, Monson JP, Besser GM, Grossman AB (1999) Menstrual irregularity in women with acromegaly. J Clin Endocrinol Metab 84(8):2731\u20132735. https:\/\/doi.org\/10.1210\/jcem.84.8.5858","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1050_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1046\/j.1365-2265.2001.01214.x","volume":"54","author":"L Katznelson","year":"2001","unstructured":"Katznelson L, Kleinberg D, Vance ML, Stavrou S, Pulaski KJ, Schoenfeld DA, Hayden DL, Wright ME, Woodburn CJ, Klibanski A (2001) Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study. Clin Endocrinol 54(2):183\u2013188. https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01214.x","journal-title":"Clin Endocrinol"},{"issue":"10","key":"1050_CR4","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.1210\/jc.2009-2815","volume":"95","author":"M Grynberg","year":"2010","unstructured":"Grynberg M, Salenave S, Young J, Chanson P (2010) Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab 95(10):4518\u20134525. https:\/\/doi.org\/10.1210\/jc.2009-2815","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1050_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12020-018-1540-5","volume":"60","author":"SC Dogansen","year":"2018","unstructured":"Dogansen SC, Tanrikulu S, Yalin GY, Yarman S (2018) Female gonadal functions and ovarian reserve in patients with acromegaly: experience from a single tertiary center. Endocrine 60(1):167\u2013174. https:\/\/doi.org\/10.1007\/s12020-018-1540-5","journal-title":"Endocrine"},{"issue":"10","key":"1050_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/erc-17-0253","volume":"24","author":"P Petrossians","year":"2017","unstructured":"Petrossians P, Daly AF, Natchev E, Maione L, Blijdorp K, Sahnoun-Fathallah M, Auriemma R, Diallo AM, Hulting AL, Ferone D, Hana V Jr, Filipponi S, Sievers C, Nogueira C, Fajardo-Montanana C, Carvalho D, Hana V, Stalla GK, Jaffrain-Rea ML, Delemer B, Colao A, Brue T, Neggers S, Zacharieva S, Chanson P, Beckers A (2017) Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) database. Endocr Relat Cancer 24(10):505\u2013518. https:\/\/doi.org\/10.1530\/erc-17-0253","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"1050_CR7","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1210\/jc.2003-030518","volume":"88","author":"DR Clemmons","year":"2003","unstructured":"Clemmons DR, Chihara K, Freda PU, Ho KK, Klibanski A, Melmed S, Shalet SM, Strasburger CJ, Trainer PJ, Thorner MO (2003) Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm. J Clin Endocrinol Metab 88(10):4759\u20134767. https:\/\/doi.org\/10.1210\/jc.2003-030518","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1050_CR8","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1365-2265.2007.02987.x","volume":"67","author":"GA Kaltsas","year":"2007","unstructured":"Kaltsas GA, Androulakis II, Tziveriotis K, Papadogias D, Tsikini A, Makras P, Dimitriou K, Stathopoulou A, Piaditis G (2007) Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly. Clin Endocrinol 67(6):917\u2013922. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02987.x","journal-title":"Clin Endocrinol"},{"issue":"5","key":"1050_CR9","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1365-2265.2009.03706.x","volume":"72","author":"P Maffei","year":"2010","unstructured":"Maffei P, Tamagno G, Nardelli GB, Videau C, Menegazzo C, Milan G, Calcagno A, Martini C, Vettor R, Epelbaum J, Sicolo N (2010) Effects of octreotide exposure during pregnancy in acromegaly. Clin Endocrinol 72(5):668\u2013677. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03706.x","journal-title":"Clin Endocrinol"},{"issue":"16","key":"1050_CR10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1056\/nejm200004203421604","volume":"342","author":"PJ Trainer","year":"2000","unstructured":"Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thorner MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strasburger CJ, Hackett S, Zib K, Bennett WF, Davis RJ (2000) Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med 342(16):1171\u20131177. https:\/\/doi.org\/10.1056\/nejm200004203421604","journal-title":"N Engl J Med"},{"issue":"9295","key":"1050_CR11","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/s0140-6736(01)06844-1","volume":"358","author":"AJ van der Lely","year":"2001","unstructured":"van der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, Klibanski A, Herman-Bonert V, Melmed S, Vance ML, Freda PU, Stewart PM, Friend KE, Clemmons DR, Johannsson G, Stavrou S, Cook DM, Phillips LS, Strasburger CJ, Hackett S, Zib KA, Davis RJ, Scarlett JA, Thorner MO (2001) Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet (London, England) 358(9295):1754\u20131759. https:\/\/doi.org\/10.1016\/s0140-6736(01)06844-1","journal-title":"Lancet (London, England)"},{"issue":"6","key":"1050_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1530\/eje-18-0616","volume":"179","author":"M Buchfelder","year":"2018","unstructured":"Buchfelder M, van der Lely AJ, Biller BMK, Webb SM, Brue T, Strasburger CJ, Ghigo E, Camacho-Hubner C, Pan K, Lavenberg J, Jonsson P, Hey-Hadavi JH (2018) Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY. Eur J Endocrinol 179(6):419\u2013427. https:\/\/doi.org\/10.1530\/eje-18-0616","journal-title":"Eur J Endocrinol"},{"key":"1050_CR13","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz187","author":"A Ghajar","year":"2019","unstructured":"Ghajar A, Jones P, Guarda FJ, Faje A, Tritos NA, Miller KK, Swearingen B, Nachtigall LB (2019) Biochemical control in acromegaly with multimodality therapies: outcomes from a pituitary center and changes over time. J Clin Endocrinol Metab. https:\/\/doi.org\/10.1210\/clinem\/dgz187","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1050_CR14","first-page":"223","volume":"76","author":"PG Whittaker","year":"1990","unstructured":"Whittaker PG, Stewart MO, Taylor A, Howell RJ, Lind T (1990) Insulin-like growth factor 1 and its binding protein 1 during normal and diabetic pregnancies. Obstet Gynecol 76(2):223\u2013229","journal-title":"Obstet Gynecol"},{"issue":"3","key":"1050_CR15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ecl.2019.05.004","volume":"48","author":"W Huang","year":"2019","unstructured":"Huang W, Molitch ME (2019) Pituitary Tumors in Pregnancy. Endocrinol Metab Clin North Am 48(3):569\u2013581. https:\/\/doi.org\/10.1016\/j.ecl.2019.05.004","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"1050_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/17446651.2019.1571909","volume":"14","author":"P Chanson","year":"2019","unstructured":"Chanson P, Vialon M, Caron P (2019) An update on clinical care for pregnant women with acromegaly. Expert Rev Endocrinol Metab 14(2):85\u201396. https:\/\/doi.org\/10.1080\/17446651.2019.1571909","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"6","key":"1050_CR17","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.beem.2011.08.001","volume":"25","author":"D Unuane","year":"2011","unstructured":"Unuane D, Tournaye H, Velkeniers B, Poppe K (2011) Endocrine disorders & female infertility. Best practice & research. Clin Endocrinol Metab 25(6):861\u2013873. https:\/\/doi.org\/10.1016\/j.beem.2011.08.001","journal-title":"Clin Endocrinol Metab"},{"issue":"1","key":"1050_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11102-016-0740-3","volume":"20","author":"A Muhammad","year":"2017","unstructured":"Muhammad A, Neggers SJ, van der Lely AJ (2017) Pregnancy and acromegaly. Pituitary 20(1):179\u2013184. https:\/\/doi.org\/10.1007\/s11102-016-0740-3","journal-title":"Pituitary"},{"issue":"5","key":"1050_CR19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/er.2003-0035","volume":"25","author":"KC Leung","year":"2004","unstructured":"Leung KC, Johannsson G, Leong GM, Ho KK (2004) Estrogen regulation of growth hormone action. Endocr Rev 25(5):693\u2013721. https:\/\/doi.org\/10.1210\/er.2003-0035","journal-title":"Endocr Rev"},{"issue":"3","key":"1050_CR20","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1073\/pnas.0337600100","volume":"100","author":"KC Leung","year":"2003","unstructured":"Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CK, Low TH, Leong GM, Ross RJ, Ho KK (2003) Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. Proc Natl Acad Sci USA 100(3):1016\u20131021. https:\/\/doi.org\/10.1073\/pnas.0337600100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1050_CR21","doi-asserted-by":"publisher","first-page":"K21","DOI":"10.1530\/eje-18-0688","volume":"180","author":"AM Hannon","year":"2019","unstructured":"Hannon AM, O'Shea T, Thompson CA, Hannon MJ, Dineen R, Khattak A, Gibney J, O'Halloran DJ, Hunter S, Thompson CJ, Sherlock M (2019) Pregnancy in acromegaly is safe and is associated with improvements in IGF-1 concentrations. Eur J Endocrinol 180(4):K21\u2013k29. https:\/\/doi.org\/10.1530\/eje-18-0688","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"1050_CR22","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1210\/jc.2009-2331","volume":"95","author":"P Caron","year":"2010","unstructured":"Caron P, Broussaud S, Bertherat J, Borson-Chazot F, Brue T, Cortet-Rudelli C, Chanson P (2010) Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab 95(10):4680\u20134687. https:\/\/doi.org\/10.1210\/jc.2009-2331","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1050_CR23","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/cen.13599","volume":"88","author":"RS Jallad","year":"2018","unstructured":"Jallad RS, Shimon I, Fraenkel M, Medvedovsky V, Akirov A, Duarte FH, Bronstein MD (2018) Outcome of pregnancies in a large cohort of women with acromegaly. Clin Endocrinol 88(6):896\u2013907. https:\/\/doi.org\/10.1111\/cen.13599","journal-title":"Clin Endocrinol"},{"issue":"6","key":"1050_CR24","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/cen.14097","volume":"91","author":"M Vialon","year":"2019","unstructured":"Vialon M, Grunenwald S, Mouly C, Vezzosi D, Bennet A, Gourdy P, Caron PJ (2019) Gestational diabetes and acromegaly: single-centre experience of 14 pregnancies. Clin Endocrinol 91(6):805\u2013809. https:\/\/doi.org\/10.1111\/cen.14097","journal-title":"Clin Endocrinol"},{"issue":"4","key":"1050_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11102-016-0717-2","volume":"19","author":"O Haliloglu","year":"2016","unstructured":"Haliloglu O, Dogangun B, Ozcabi B, Kural HU, Keskin FE, Ozkaya HM, Pamukcu FC, Bektas E, Poyraz BC, Buber H, Evliyaoglu O, Kadioglu P (2016) General health status and intelligence scores of children of mothers with acromegaly do not differ from those of healthy mothers. Pituitary 19(4):391\u2013398. https:\/\/doi.org\/10.1007\/s11102-016-0717-2","journal-title":"Pituitary"},{"issue":"2","key":"1050_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1530\/eje-13-0460","volume":"170","author":"M Dias","year":"2014","unstructured":"Dias M, Boguszewski C, Gadelha M, Kasuki L, Musolino N, Vieira JG, Abucham J (2014) Acromegaly and pregnancy: a prospective study. Eur J Endocrinol 170(2):301\u2013310. https:\/\/doi.org\/10.1530\/eje-13-0460","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1050_CR27","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1365-2265.2011.04180.x","volume":"76","author":"S Cheng","year":"2012","unstructured":"Cheng S, Grasso L, Martinez-Orozco JA, Al-Agha R, Pivonello R, Colao A, Ezzat S (2012) Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature. Clin Endocrinol 76(2):264\u2013271. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04180.x","journal-title":"Clin Endocrinol"},{"issue":"11","key":"1050_CR28","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951. https:\/\/doi.org\/10.1210\/jc.2014-2700","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1050_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11102-016-0753-y","volume":"20","author":"NA Tritos","year":"2017","unstructured":"Tritos NA, Biller BM (2017) Pegvisomant: a growth hormone receptor antagonist used in the treatment of acromegaly. Pituitary 20(1):129\u2013135. https:\/\/doi.org\/10.1007\/s11102-016-0753-y","journal-title":"Pituitary"},{"issue":"9","key":"1050_CR30","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrendo.2010.123","volume":"6","author":"AJ Brooks","year":"2010","unstructured":"Brooks AJ, Waters MJ (2010) The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol 6(9):515\u2013525. https:\/\/doi.org\/10.1038\/nrendo.2010.123","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"1050_CR31","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s12020-014-0508-3","volume":"49","author":"AJ van der Lely","year":"2015","unstructured":"van der Lely AJ, Gomez R, Heissler JF, Akerblad AC, Jonsson P, Camacho-Hubner C, Koltowska-Haggstrom M (2015) Pregnancy in acromegaly patients treated with pegvisomant. Endocrine 49(3):769\u2013773. https:\/\/doi.org\/10.1007\/s12020-014-0508-3","journal-title":"Endocrine"},{"issue":"11\u201312","key":"1050_CR32","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10815-006-9077-6","volume":"23","author":"A Qureshi","year":"2006","unstructured":"Qureshi A, Kalu E, Ramanathan G, Bano G, Croucher C, Panahloo A (2006) IVF\/ICSI in a woman with active acromegaly: successful outcome following treatment with pegvisomant. J Assist Reprod Genet 23(11\u201312):439\u2013442. https:\/\/doi.org\/10.1007\/s10815-006-9077-6","journal-title":"J Assist Reprod Genet"},{"issue":"9","key":"1050_CR33","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1210\/jc.2007-0997","volume":"92","author":"SR Brian","year":"2007","unstructured":"Brian SR, Bidlingmaier M, Wajnrajch MP, Weinzimer SA, Inzucchi SE (2007) Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab 92(9):3374\u20133377. https:\/\/doi.org\/10.1210\/jc.2007-0997","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01050-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-020-01050-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01050-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:48:48Z","timestamp":1621885728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-020-01050-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,25]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1050"],"URL":"https:\/\/doi.org\/10.1007\/s11102-020-01050-2","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,25]]},"assertion":[{"value":"25 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"WG, FJG and AG: none. MG received honoraria for consulting from Pfizer and Sanofi-Aventis and from Novartis for an ongoing trial. LBN received honoraria for consulting from Pfizer and Ipsen, and research funds from Ipsen and Chiasma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional Review Board of Partners Healthcare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable for retrospective observational study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable for retrospective observational study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}